GHRP-2
Growth Hormone Releasing Peptide-2 (Pralmorelin)
Classic GH releaser — stronger pulse than Ipamorelin
About
A synthetic ghrelin receptor agonist that triggers strong GH release. More potent GH pulse than Ipamorelin but with side effects: elevated cortisol, prolactin, and intense hunger.
Mechanism
Binds GHS-R1a receptors in the pituitary to trigger GH release; also stimulates ghrelin's appetite pathway.
Dosage
Draw to 4 units on a U-100 insulin syringe
5 mg · 2 mL BAC
When to take: Empty stomach, 30-60 min before food. Avoid sugar/carbs 30 min before to prevent GH blunting.
Reconstitution
Vial size (mg): 5 mg · BAC water (mL): 2 mL · Concentration: 2500 mcg/mL
Frequently stacked with CJC-1295 in the same syringe.
Benefits
- Strong GH and IGF-1 elevation
- Improved sleep depth
- Muscle building
- Cheaper than Ipamorelin
- Useful for breaking lean-muscle plateaus
Side effects
- Intense hunger surge (often within 30 min)
- Elevated cortisol (transient stress)
- Elevated prolactin (can affect libido long-term)
- Water retention
- Tingling in hands
Gender notes
Cautions
- Active cancer (hard contraindication)
- Pregnancy and breastfeeding
- Diabetes (monitor blood glucose)
- Pituitary tumors
- Hyperprolactinemia history
Research
- Bowers CY: Growth hormone-releasing peptide (GHRP)
Cellular and Molecular Life Sciences · 1998
Original characterization of GHRP family by the discoverer; reviews structure-activity and clinical potential.
- Laferrère B et al: GHRP-2 increases food intake in healthy humans
Journal of Clinical Endocrinology & Metabolism · 2005
GHRP-2 stimulates appetite ~2-3x in healthy adults, explaining the hunger side effect.